Our study reveals a clear role for the microbiota in maintenance of a homeostatic antiviral state, driven by IL-22, against rotavirus infection, and future studies delineating the specific pathways required for this activity may help reveal additional therapeutic approaches against this pathogen. The gene discussed is IL22; the disease is Rotavirus infection.